Design of potentially active ligands for SH2 domains by molecular modeling methods
暂无分享,去创建一个
Vasyl V. Hurmach | O. M. Balinskyi | M. O. Platonov | O. M. Boyko | P. O. Borysko | Yu. I. Prylutskyy | M. Platonov | V. Hurmach | Y. Prylutskyy | O. Balinskyi | O. M. Boyko | Petro O. Borysko
[1] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[2] C. E. Peishoff,et al. A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.
[3] O. M. Balinskyi,et al. Geometric filters for protein-ligand complexes based on phenomenological molecular models , 2013 .
[4] T Pawson,et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.
[5] Corinne M. Silva. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis , 2004, Oncogene.
[6] T. Pawson,et al. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. , 2006, Molecular cell.
[7] Colin McMartin,et al. QXP: Powerful, rapid computer algorithms for structure-based drug design , 1997, J. Comput. Aided Mol. Des..
[8] T Pawson,et al. SH2 domains, interaction modules and cellular wiring. , 2001, Trends in cell biology.
[9] Alexander Chuprina,et al. Drug- and Lead-likeness, Target Class, and Molecular Diversity Analysis of 7.9 Million Commercially Available Organic Compounds Provided by 29 Suppliers , 2010, J. Chem. Inf. Model..
[10] Wee Kheng Leow,et al. Knowledge-Guided Docking of Flexible Ligands to SH2 Domain Proteins , 2010, 2010 IEEE International Conference on BioInformatics and BioEngineering.
[11] A. Arkin,et al. Biological networks. , 2003, Current opinion in structural biology.